Fundraising FoxManzara Therapeutics
New York, US · Founded 2017 · Delaware corporation
Find your way into Manzara Therapeutics
Sign up to see every warm intro you have to Manzara Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Manzara Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
HR
Herschel RabitzNamed on SEC filing
AC
Amalavoyal ChariNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$750K disclosed across 1 round · 2018
▶$750KraisedNov 2018 · 9 investors · Other Health CareRule 506(b)
▶$750KraisedNov 2018 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Herschel RabitzDirector
- Amalavoyal ChariExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $750K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Manzara Therapeutics raised?
- Manzara Therapeutics has disclosed $750K raised across 1 round.
- Where is Manzara Therapeutics headquartered?
- Manzara Therapeutics is headquartered in New York, US.